Characterizing familial chylomicronemia syndrome: baseline data of the APPROACH study (2018)
- Authors:
- Autor USP: SANTOS FILHO, RAUL DIAS DOS - FM
- Unidade: FM
- DOI: 10.1016/j.jacl.2018.05.013
- Subjects: HIPERLIPIDEMIA; DOENÇAS GENÉTICAS; HIPERTRIGLICERIDEMIA; PANCREATITE; DIETA COM RESTRIÇÃO DE GORDURAS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Journal of clinical lipidology
- ISSN: 1933-2874
- Volume/Número/Paginação/Ano: v. 12, n. 5, p. 1234-1243, 2018
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: hybrid
- Licença: cc-by-nc-nd
-
ABNT
BLOM, Dirk J. et al. Characterizing familial chylomicronemia syndrome: baseline data of the APPROACH study. Journal of clinical lipidology, v. 12, n. 5, p. 1234-1243, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.jacl.2018.05.013. Acesso em: 12 jun. 2024. -
APA
Blom, D. J., O'dea, L., Digenio, A., Alexander, V. J., Karwatowska-Prokopczuk, E., Williams, K. R., et al. (2018). Characterizing familial chylomicronemia syndrome: baseline data of the APPROACH study. Journal of clinical lipidology, 12( 5), 1234-1243. doi:10.1016/j.jacl.2018.05.013 -
NLM
Blom DJ, O'dea L, Digenio A, Alexander VJ, Karwatowska-Prokopczuk E, Williams KR, Hemphill L, Muniz-Grijalvo O, Santos Filho RD dos, Baum S, Witztum JL. Characterizing familial chylomicronemia syndrome: baseline data of the APPROACH study [Internet]. Journal of clinical lipidology. 2018 ; 12( 5): 1234-1243.[citado 2024 jun. 12 ] Available from: https://doi.org/10.1016/j.jacl.2018.05.013 -
Vancouver
Blom DJ, O'dea L, Digenio A, Alexander VJ, Karwatowska-Prokopczuk E, Williams KR, Hemphill L, Muniz-Grijalvo O, Santos Filho RD dos, Baum S, Witztum JL. Characterizing familial chylomicronemia syndrome: baseline data of the APPROACH study [Internet]. Journal of clinical lipidology. 2018 ; 12( 5): 1234-1243.[citado 2024 jun. 12 ] Available from: https://doi.org/10.1016/j.jacl.2018.05.013 - Foi com muita satisfação que recebemos o convite dos ...[Apresentação]
- Relation of Uric Acid to Serum Levels of High-Sensitivity C-Reactive Protein, Triglycerides, and High-Density Lipoprotein Cholesterol and to Hepatic Steatosis
- Homozygous familial hypercholesterolemia: Current perspectives on diagnosis and treatment
- Elevated uric acid, the metabolic syndrome and cardiovascular disease [Editorial]: cause, consequence, or just a not so innocent bystander?
- Lipid-lowering treatment for homozygous familial hypercholesterolaemia [Carta]
- Statin Use Is Not Associated With Presence of and Severity of Nonalcoholic Fatty Liver Disease
- A systematic review: Burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; Should we care?
- Relation of Hepatic Steatosis to Atherogenic Dyslipidemia
- Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
- Cigarette smoking worsens systemic inflammation in persons with metabolic syndrome
Informações sobre o DOI: 10.1016/j.jacl.2018.05.013 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas